Macfarlanes advised Alchemy Partners on the deal. Alchemy Partners closed its latest fund, Alchemy Special Opportunities Fund V, securing €1bn in capital commitments and surpassing its...
Alchemy’s €1 Billion Closing of Alchemy Special Opportunities Fund V (ASOF V)
Proclinic Group’s €200 Million Financing From Miura Partners And Keyhaven Capital Partners
Baker & McKenzie and King & Wood Mallesons acted for Miura Partners; Macfarlanes advised Keyhaven Capital Partners. Miura Partners (Miura) closed the Dent&Co fund with more...
Dawn Capital’s $700 Million Fundraise
Macfarlanes has advised Dawn Capital on the raise. Dawn Capital is Europe’s largest specialist B2B software investor. The firm partners with innovative companies that, through exceptional...
Littelfuse’s Acquisition of C&K Switches
Wachtell, Lipton, Rosen & Katz and Macfarlanes represented Littelfuse in the transaction. Ashurst advised Sun Capital Partners. Littelfuse, Inc. has entered into a definitive agreement with...